The MAPK/ERK (mitogen-activated protein kinase/extracellular signal-regulated kinase) pathway (also known as RAS-RAF-MEK-ERK) has been identified as a way to evade SMO inhibition and drive tumor evolution in HH-dependent tumors. The gene discussed is SMO; the disease is neoplasm.